Loading clinical trials...

Use of an Investigational Digital Therapeutic in Patients With Type 2 Diabetes | Clinical Trials | Clareo Health

TERMINATEDPhase 3NCT05094401

Use of an Investigational Digital Therapeutic in Patients With Type 2 Diabetes

BT-001 is a software program intended to help patients with type 2 diabetes, under the guidance of their physician, improve glycemic control (i.e., levels of blood sugar). The BT-001 software delivers...

Lead sponsor: Better Therapeutics•1 U.S. locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Clareo turns complex medical information into clear understanding you can use.

Bring this clarity to your next appointment.

Keep all your medical notes and next steps in one place.

Start Free Trial

Related studies

RECRUITINGNA

Clinical Study to Assess the Safety, Efficacy and In-Use Tolerability of Herbal-Based Sugar Support Effervescent Tablets in Type-2 Diabetes Mellitus Patients

NCT06961019 · Type2 Diabetes Mellitus

RECRUITING

A Causative Role for Amylin in Diabetic Peripheral Neuropathy

NCT03481283 · Type2 Diabetes, Peripheral Neuropathy

RECRUITING

Brain Health in Youth With Normal Weight, Overweight and Obesity at Risk for Type 2 Diabetes (T2D)

NCT05277558 · Type2 Diabetes, Type 2 Diabetes Mellitus in Obese, and more

RECRUITING

UK Imaging Diabetes Study Seeing Diabetes Clearly

NCT05057403 · Type2 Diabetes

RECRUITINGNA

Whey or Casein - Liver Fat Reduction and Metabolic Improvement by Fast vs. Slow Proteins

NCT04564391 · Type2 Diabetes, NAFLD

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: September 28, 2023Terms

Trial snapshot

StatusTERMINATED

PhasePHASE3

Enrollment76

Start dateOct 2021

Last updatedSep 28, 2023

Condition

Type2 Diabetes

Locations shown

Catalyst Health Network

Plano, Texas

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: September 28, 2023Data synced to Clareo: May 10, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions

Use of an Investigational Digital Therapeutic in Patients With Type 2 Diabetes

What this study is about

Clareo turns complex medical information into clear understanding you can use.

Sponsors

Related studies

Clinical Study to Assess the Safety, Efficacy and In-Use Tolerability of Herbal-Based Sugar Support Effervescent Tablets in Type-2 Diabetes Mellitus Patients

A Causative Role for Amylin in Diabetic Peripheral Neuropathy

Brain Health in Youth With Normal Weight, Overweight and Obesity at Risk for Type 2 Diabetes (T2D)

UK Imaging Diabetes Study Seeing Diabetes Clearly

Whey or Casein - Liver Fat Reduction and Metabolic Improvement by Fast vs. Slow Proteins

Trial snapshot

Condition

Locations shown

For caregivers